China NMPA Product Recall - Medical oxygen concentrator

On January 8, 2019, the National Medical Products Administration (NMPA) announced that Sichuan Da'ai Technology Co., Ltd. initiated a voluntary Class III recall of specific medical oxygen concentrators. This action was taken after the Sichuan Provincial Medical Device Quality Supervision and Inspection Center discovered that several of the company's products did not adhere to required quality standards. The affected devices, covered under Registration Certificate No. 川械注准20172540190, were identified as non-compliant, leading to the company's proactive measure to address the issue. The recall primarily addresses concerns regarding product quality and safety, as the devices failed to meet established regulatory benchmarks. Although specific details of the non-compliance are not provided in this announcement, the recall level (Class III) typically indicates that exposure to the product is unlikely to cause adverse health consequences, but the product violates NMPA regulations. The regulatory framework for this action involves both the NMPA, which hosts the official announcement, and the provincial quality supervision center responsible for the initial detection. Sichuan Da'ai Technology Co., Ltd. is required to remove the affected batches from circulation, with comprehensive details on models, specifications, and batch numbers available in the "Medical Device Recall Event Report Form" attachment. This incident highlights the ongoing efforts by regulatory bodies to ensure that medical devices consistently meet stringent safety and efficacy standards for public health protection.